Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers

AIMS: The aim of this study was to assess the effect of the cytochrome P450 (CYP) 3A4 and organic anion-transporting polypeptide (OATP) 1B1 inhibitor clarithromycin on the pharmacokinetics of bosentan. We also aimed to evaluate the impact of CYP2C9 and SLCO1B1 (encoding for OATP1B1) genotypes and th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Markert, Christoph, Schweizer, Yvonne, Hellwig, Regina, Wirsching, Theresia, Riedel, Klaus-Dieter, Burhenne, Juergen, Weiss, Johanna, Mikus, Gerd, Haefeli, Walter E
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2014
Assuntos:
Pharmacokinetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3895355/
https://ncbi.nlm.nih.gov/pubmed/23738582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados